Cargando…
Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
DNA methylation is an epigenetic mechanism in the pathogenesis of hepatocellular carcinoma (HCC). Here, we conducted a systematic meta-analysis to evaluate the contribution of DNA methylation to the risk of HCC. A total of 2109 publications were initially retrieved from PubMed, Web of Science, Cochr...
Autores principales: | Zhang, Cheng, Li, Jinyun, Huang, Tao, Duan, Shiwei, Dai, Dongjun, Jiang, Danjie, Sui, Xinbing, Li, Da, Chen, Yidan, Ding, Fei, Huang, Changxin, Chen, Gongying, Wang, Kaifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348390/ https://www.ncbi.nlm.nih.gov/pubmed/27835605 http://dx.doi.org/10.18632/oncotarget.13221 |
Ejemplares similares
-
Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis
por: Zhang, Cheng, et al.
Publicado: (2019) -
Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis
por: Huang, Tao, et al.
Publicado: (2016) -
Investigation into the promoter DNA methylation of three genes (CAMK1D, CRY2 and CALM2) in the peripheral blood of patients with type 2 diabetes
por: CHENG, JIA, et al.
Publicado: (2014) -
Association of CDKN2BAS Polymorphism rs4977574 with Coronary Heart Disease: A Case-Control Study and a Meta-Analysis
por: Huang, Yi, et al.
Publicado: (2014) -
Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease
por: Xu, Xiaofeng, et al.
Publicado: (2018)